{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-074314","form_type":"8-K","ticker":"CYRX","cik":"0001124524","company_name":"Cryoport, Inc.","filed_at":"2025-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.390357+00:00","generated_at":"2026-05-17T18:53:58.224605+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cryoport Q2 revenue up 14% to $45.5M; cell & gene therapy revenue +33%; reaffirms FY25 guidance","bullets":["Net income of $105.2M includes $117.4M gain from CRYOPDP divestiture; adjusted EBITDA improved to -$0.9M vs -$5.6M a year ago.","Life Sciences Services revenue grew 21% to $24.4M (54% of total); BioStorage/BioServices up 28%.","Commercial cell & gene therapy revenue rose 33% to $8.7M; supported 18 commercial therapies and 728 global trials.","Closed strategic partnership with DHL and divestiture of CRYOPDP on June 11, 2025; cash & investments $426M.","Reaffirmed FY2025 revenue guidance of $165M–$172M, representing 5%-10% YoY growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-074314","json":"https://secwatch.observer/filing/0001104659-25-074314.json","markdown":"https://secwatch.observer/filing/0001104659-25-074314.md","text":"https://secwatch.observer/filing/0001104659-25-074314.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1124524/000110465925074314/0001104659-25-074314-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1124524/000110465925074314/tm2522626d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T18:53:58.224605+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}